The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Low-dose aspirin to reduce recurrence rate in colorectal cancer patients with PI3K pathway alterations: 3-year results from a randomized placebo-controlled trial.
 
Anna Martling
Leadership - Bactiguard; Smartcella
Stock and Other Ownership Interests - AstraZeneca; Bactiguard; Smartcella
Consulting or Advisory Role - CarpoNovum
 
Johan Lindberg
Stock and Other Ownership Interests - LPO - Lighthouse Precision Oncology
Honoraria - AstraZeneca; Janssen-Cilag AB; Pfizer
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
Patents, Royalties, Other Intellectual Property - European Patent Application No. PCT/SE2024/050638, METHOD OF IDENTIFYING AND ADJUSTING FOR SYSTEMATIC VARIABILITY IN DNA ABUNDANCE MEASUREMENTS.
Travel, Accommodations, Expenses - Janssen
 
Ida Hed Myrberg
No Relationships to Disclose
 
Mef Nilbert
No Relationships to Disclose
 
Markus Mayrhofer
Stock and Other Ownership Interests - Lighthouse Precision Oncology AB
Patents, Royalties, Other Intellectual Property - European Patent Application: METHOD OF IDENTIFYING AND ADJUSTING FOR SYSTEMATIC VARIABILITY IN DNA ABUNDANCE MEASUREMENTS
 
Henrik Gronberg
Leadership - A3P Biomedical
Honoraria - Astellas Pharma; Bayer; BMS; Janssen Oncology; Pfizer
Research Funding - AstraZeneca (Inst); Janssen Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Henrik Grönberg has five prostate cancer diagnostic related patents pending.
 
Bengt Glimelius
No Relationships to Disclose
 
ALASCCA Trial Study Group
No Relationships to Disclose